Coherus BioSciences Inc Cash Flow Reinvestment Rate
Coherus BioSciences Inc cash flow reinvestment rate. Coherus BioSciences Inc (CHRS) has a Cash Flow Reinvestment Rate of 0.02x as of December 2024, reinvesting $542.00K (capex $0.00 plus investments $-542.00K) from operating cash flow of $28.61 Million. Explore debt repayment capacity of Coherus BioSciences Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Coherus BioSciences Inc (2013–2020)
Cash flow reinvestment rate of Coherus BioSciences Inc from 2013 to 2020. Historical reinvestment intensity for Coherus BioSciences Inc across 3 annual periods. Explore CHRS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Coherus BioSciences Inc Cash Flow Reinvestment Rate by Year (2013–2020)
Coherus BioSciences Inc cash flow reinvestment rate by year from 2013 to 2020. Year-by-year capital reinvestment analysis for Coherus BioSciences Inc. For the full cash flow conversion analysis, see Coherus BioSciences Inc (CHRS) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $7.39 Million | $154.15 Million | $7.23 Million | ▼ -89.6% |
| 2019 | 0.46x | $13.06 Million | $28.36 Million | $12.90 Million | ▲ +1804.8% |
| 2013 | 0.02x | $373.00K | $15.42 Million | $373.00K | — |